EUVIMEDEUVIMED entdecken
Crossref

Hypofractionated radiation therapy alone for human papillomavirus‐related oropharyngeal cancer

Allen M Chen, Jeremy P Harris, Tjoson Tjoa, Yarah Haidar, William B Armstrong

Head & Neck · 2025

DOI: 10.1002/hed.27908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Allen M Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of California, Irvine, Chao Family Comprehensive Cancer Center, Orange, California, USA. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Radiation Dose Hypofractionation, Papillomavirus Infections. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To report a single‐institutional experience with hypofractionated radiation therapy alone for human papillomavirus (HPV)‐positive oropharyngeal cancer. Methods and materials A total of 101 consecutive patients were treated by radiation therapy alone using a regimen of 66 Gy in 30 fractions (60 patients) or 70 Gy in 33 fractions (41 patients) for newly diagnosed p16‐positive squamous cell carcinoma of the oropharynx. Sixty‐seven patients (67%) were never smokers.

Results

The 3‐year actuarial rates of overall survival, local‐regional control, and progression‐free survival were 94%, 93%, and 89%, respectively. Among never‐smokers, the 3‐year rates of overall survival and local–regional control were 98% and 100%, respectively. The grade 3+ acute toxicity rate was 21%, with the most commonly observed side effects related to mucositis.

Conclusion

Hypofractionated radiation alone resulted in excellent outcomes for patients with HPV‐positive oropharyngeal cancer. A prospective clinical trial investigating this modality in the setting of de‐escalation is currently underway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oropharyngeal NeoplasmsRadiation Dose HypofractionationPapillomavirus InfectionsHumansMaleMiddle AgedFemaleAgedAdultAged, 80 and overCarcinoma, Squamous CellRetrospective StudiesTreatment OutcomeHuman Papillomavirus Viruses

Stichwörter der Autor:innen

HPVcancerhypofractionationoropharyngealradiation

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of California, Irvine, Chao Family Comprehensive Cancer Center, Orange, California, USA.
  • Department of Otolaryngology, University of California, Irvine, Chao Family Comprehensive Cancer Center, Orange, California, USA.

Zitieren

APA

Chen, A. M., Harris, J. P., Tjoa, T., Haidar, Y., & Armstrong, W. B. (2025). Hypofractionated radiation therapy alone for human papillomavirus‐related oropharyngeal cancer. Head & Neck. https://doi.org/10.1002/hed.27908

Vancouver

Chen AM, Harris JP, Tjoa T, Haidar Y, Armstrong WB. Hypofractionated radiation therapy alone for human papillomavirus‐related oropharyngeal cancer. Head & Neck. 2025. doi:10.1002/hed.27908

BibTeX
@article{Chen2025,
  author = {Chen, Allen M and Harris, Jeremy P and Tjoa, Tjoson and Haidar, Yarah and Armstrong, William B},
  title = {Hypofractionated radiation therapy alone for human papillomavirus‐related oropharyngeal cancer},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.27908}
}
Kostenlos starten →